Hohl Benjamin: insider trades.
Hohl Benjamin reported 12 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 10 sales ($972K), across 1 company.
- Transactions
- 12
- Purchases (P)
- 0
- Sales (S)
- 10
- Companies
- 1
- Name as filed
- Hohl Benjamin
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Enliven Therapeutics, Inc. (ELVN) | Officer · CHIEF FINANCIAL OFFICER | 12 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-17 | Enliven Therapeutics, Inc. | M | 3,982 | $14.85 | 44,018 | Form 4 |
| 2026-09-17 | Enliven Therapeutics, Inc. | S | 3,535 | $50.03 | 40,483 | Form 4 |
| 2026-09-17 | Enliven Therapeutics, Inc. | S | 2,194 | $50.72 | 38,289 | Form 4 |
| 2026-09-17 | Enliven Therapeutics, Inc. | S | 289 | $51.49 | 38,000 | Form 4 |
| 2026-08-17 | Enliven Therapeutics, Inc. | S | 4,630 | $58.35 | 41,424 | Form 4 |
| 2026-08-17 | Enliven Therapeutics, Inc. | S | 1,388 | $59.35 | 40,036 | Form 4 |
| 2026-07-17 | Enliven Therapeutics, Inc. | S | 123 | $53.87 | 46,054 | Form 4 |
| 2026-07-17 | Enliven Therapeutics, Inc. | S | 2,638 | $53.38 | 46,177 | Form 4 |
| 2026-07-17 | Enliven Therapeutics, Inc. | M | 1,072 | $2.48 | 52,072 | Form 4 |
| 2026-07-17 | Enliven Therapeutics, Inc. | S | 324 | $49.97 | 51,748 | Form 4 |
| 2026-07-17 | Enliven Therapeutics, Inc. | S | 369 | $51.48 | 51,379 | Form 4 |
| 2026-07-17 | Enliven Therapeutics, Inc. | S | 2,564 | $52.32 | 48,815 | Form 4 |
Questions
What stock did Hohl Benjamin buy or sell?
Hohl Benjamin reported 12 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 10 sales ($972K), across 1 company.
Is Hohl Benjamin the same person as other filers with this name?
This page covers SEC CIK 1882764 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/hohl-benjamin-1882764.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.